The US Food and Drug Administration (FDA) has approved a drug which has been found to allow patients with multiple sclerosis (MS) walk faster, the drug watchdog said.
The US Food and Drug Administration (FDA) has approved a drug which has been found to allow patients with multiple sclerosis (MS) walk faster, the drug watchdog said.
Multiple sclerosis patients treated with the drug, Ampyra - generic name dalfampridine - were found in clinical trials to have faster walking speeds than those treated with a placebo, the FDA said.
Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses
Ampyra is the first drug approved by the FDA to help improve MS patients' walking.
Multiple sclerosis is a chronic, often disabling disease that affects the brain, spinal cord and optic nerves.
Multiple Sclerosis Progression Slows In Women Who Give Birth
According to a new study, the progression of multiple sclerosis, a long-term inflammatory condition of the central nervous system gets slower in women who give birth.
According to a new study, the progression of multiple sclerosis, a long-term inflammatory condition of the central nervous system gets slower in women who give birth.
Source-AFP
THK
Higher Multiple Sclerosis Risk for Babies Born in April
Babies born in April carry a far greater risk of suffering from neurological disease, like multiple sclerosis, experts said.
Babies born in April carry a far greater risk of suffering from neurological disease, like multiple sclerosis, experts said.
